ICU.NASDAQSeastar Medical Holding CORP

8-K: SeaStar Medical CFO Exits, CEO Takes Interim Finance Role

Sentiment:

Management Change Announcement

📋All filings for Seastar Medical Holding CORP
🔒Login to Follow

SeaStar Medical Holding Corporation announced the termination of its Chief Financial Officer, David Green, and the appointment of CEO Eric Schlorff as interim CFO.

Worse than expectedThe termination of a Chief Financial Officer without Cause often signals internal challenges or a lack of alignment, which can be viewed negatively by investors.The associated severance costs of approximately $300,000 represent an unexpected expense for the company.The appointment of an interim CFO, while necessary, indicates a period of transition and potential disruption to financial leadership.

Summary

  • SeaStar Medical Holding Corporation terminated the employment of David Green, its Chief Financial Officer and Treasurer, effective August 14, 2025.
  • The termination was without Cause, as defined in Mr. Green's employment agreement.
  • The company expects to pay Mr. Green approximately $300,000 in continued base salary over 12 months as termination payments.
  • Mr. Green is also eligible for COBRA coverage for up to 18 months, if timely elected.
  • Unvested restricted stock units granted to Mr. Green will have their vesting accelerated.
  • On August 19, 2025, the Board appointed Eric Schlorff, the company's Chief Executive Officer, as the principal financial officer, interim Chief Financial Officer, and Treasurer.
  • The company is conducting a search for a permanent replacement for the CFO role.
  • On August 19, 2025, Bradford Towne, the company's Controller, was appointed as the principal accounting officer.
  • Mr. Towne, age 48, has served as Controller since February 2024 and has extensive experience including roles at JAL Equity, Aytu BioPharma, Gevo, Inc., and 10 years in audit at KPMG, LLP.

Sentiment

Score: 4

Explanation: The termination of a CFO without cause, coupled with severance costs and the need for an interim replacement, introduces uncertainty and potential disruption, leading to a moderately negative sentiment.

Positives

  • The appointment of Bradford Towne, an experienced Certified Public Accountant with a strong background in corporate accounting and audit, as Principal Accounting Officer provides stability in financial reporting.
  • CEO Eric Schlorff stepping in as interim CFO demonstrates leadership continuity during the transition period.

Negatives

  • The termination of the Chief Financial Officer without Cause introduces uncertainty regarding the company's financial leadership and potential underlying issues.
  • The company expects to incur approximately $300,000 in termination payments to the former CFO over 12 months, plus potential COBRA costs, representing a financial outlay.

Risks

  • Disruption to financial operations and strategic planning due to the unexpected departure of a key financial executive.
  • Uncertainty during the search for a permanent Chief Financial Officer, which could impact investor confidence.
  • Potential for increased workload on existing management, particularly the CEO, while serving in an interim CFO capacity.

Future Outlook

The company will conduct a search for a permanent Chief Financial Officer and Treasurer.

Industry Context

This announcement reflects a significant internal management change for SeaStar Medical, a company operating in the medical sector. Such executive transitions are common across industries but can introduce periods of uncertainty, particularly when a key financial role is affected.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial Officer and TreasurerDavid GreenAugust 14, 2025Termination without Cause by the Board of Directors.
Principal Financial Officer, Interim Chief Financial Officer and TreasurerEric SchlorffAugust 19, 2025Appointment by the Board of Directors following the termination of the previous CFO.
Principal Accounting OfficerBradford TowneAugust 19, 2025Appointment by the Board of Directors.

Stakeholder Impact

  • Shareholders may experience increased uncertainty regarding the company's financial stability and future direction due to the unexpected CFO departure.
  • Employees may perceive a period of instability within senior management.
  • The departing CFO, David Green, will receive significant termination payments and benefits.

Next Steps

  • Conduct a search for a permanent Chief Financial Officer and Treasurer.

Key Dates

DateDescription
August 13, 2025Board of Directors terminated the employment of David Green, Chief Financial Officer and Treasurer, effective August 14, 2025.
August 14, 2025Effective date of David Green's termination as Chief Financial Officer and Treasurer.
August 19, 2025Board of Directors appointed Eric Schlorff as principal financial officer, interim Chief Financial Officer and Treasurer.
August 19, 2025Board of Directors appointed Bradford Towne as principal accounting officer.
February 2024Bradford Towne began serving as Controller of SeaStar Medical.
May 2023Bradford Towne began providing consulting and accounting services as self-employed.
February 2024Bradford Towne concluded providing consulting and accounting services as self-employed.
August 2022Bradford Towne began serving as Chief Accounting Officer of JAL Equity.
May 2023Bradford Towne concluded serving as Chief Accounting Officer of JAL Equity.
June 2019Bradford Towne began serving as Corporate Controller of Aytu BioPharma, Inc.
February 2022Bradford Towne concluded serving as Corporate Controller of Aytu BioPharma, Inc.
January 2018Bradford Towne began serving as Chief Accounting Officer of Gevo, Inc.
June 2019Bradford Towne concluded serving as Chief Accounting Officer of Gevo, Inc.

Recommendation

hold

The unexpected termination of a CFO without cause introduces a degree of uncertainty and potential disruption to the company's financial operations and strategic direction. While the appointment of an experienced interim CFO and a new principal accounting officer provides some stability, investors should hold their positions and monitor the company's progress in securing a permanent CFO and any subsequent financial disclosures before making further investment decisions.

Keywords

SeaStar Medical, CFO, Chief Financial Officer, management change, executive appointment, corporate governance, financial officer, accounting officer, Eric Schlorff, Bradford Towne, David Green

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.